The road to competitive generic drug prices in Canada
- PMID: 23166285
- PMCID: PMC3778465
- DOI: 10.1503/cmaj.121367
The road to competitive generic drug prices in Canada
Figures

Similar articles
-
Generic drug prices fall overall in '94.Hosp Mater Manage. 1995 Feb;20(2):1, 12-3. Hosp Mater Manage. 1995. PMID: 10140171 No abstract available.
-
Generic pharmaceutical prices continue their decline in prices from last year.Hosp Mater Manage. 1996 Feb;21(2):1, 12-3. Hosp Mater Manage. 1996. PMID: 10154299 No abstract available.
-
Pharmaceuticals and medical devices: cost savings.Issue Brief Health Policy Track Serv. 2009 Jan 5:1-20. Issue Brief Health Policy Track Serv. 2009. PMID: 19297717 No abstract available.
-
Drug importation and safety of drugs obtained from Canada.Ann Pharmacother. 2007 Jul;41(7):1288-91. doi: 10.1345/aph.1K249. Epub 2007 Jun 19. Ann Pharmacother. 2007. PMID: 17578879 Review.
-
High Prices for Drugs With Generic Alternatives: The Curious Case of Duexis.JAMA Intern Med. 2017 Mar 1;177(3):305-306. doi: 10.1001/jamainternmed.2016.8423. JAMA Intern Med. 2017. PMID: 28114637 Review. No abstract available.
Cited by
-
Pan-Canadian overpricing of medicines: a 6-country study of cost control for generic medicines.Open Med. 2014 Oct 14;8(4):e130-5. eCollection 2014. Open Med. 2014. PMID: 25426181 Free PMC article. No abstract available.
-
The Impact of Tiered-Pricing Framework on Generic Entry in Canada.Int J Health Policy Manag. 2022 Jun 1;11(6):768-776. doi: 10.34172/ijhpm.2020.215. Int J Health Policy Manag. 2022. PMID: 33233033 Free PMC article.
-
A Better Prescription: Advice for a National Strategy on Pharmaceutical Policy in Canada.Healthc Policy. 2016 Aug;12(1):18-36. Healthc Policy. 2016. PMID: 27585023 Free PMC article.
-
Ontario and New Zealand Pharmaceuticals: Cost and Coverage.Healthc Policy. 2018 May;13(4):23-34. doi: 10.12927/hcpol.2018.25496. Healthc Policy. 2018. PMID: 30052187 Free PMC article.
-
The pan-Canadian Tiered Pricing Framework and Chinese National Volume-Based Procurement: A comparative study using Donabedian's structure-process-outcome framework.J Glob Health. 2023 Nov 10;13:04137. doi: 10.7189/jogh.13.04137. J Glob Health. 2023. PMID: 37947028 Free PMC article.
References
-
- Health Care Innovation Working Group From innovation to action: the first report of the Health Care Innovation Working Group. Ottawa (ON): The Council of the Federation; 2012. Available: www.councilofthefederation.ca/pdfs/Health%20Innovation%20Report-E-WEB.pdf (accessed 2012 July 26).
-
- Drivers of prescription drug spending in Canada. Ottawa (ON): Canadian Institute for Health Information; 2012. Available: www.cihi.ca/CIHI-ext-portal/pdf/internet/DRUG_SPEND_DRIVERS_EN (accessed 2012 July 24).
-
- The role of the generic pharmaceutical industry in Canadian health — 2011. Toronto (ON): Canadian Generic Pharmaceutical Association; 2012. Available: www.canadiangenerics.ca/en/advocacy/docs/The%20Role%20of%20the%20Generic... (accessed 2012 July 23).
-
- Lexchin J. Pharmaceuticals, patents, and politics: Canada and Bill C-22. Int J Health Serv 1993;23:147–60 - PubMed
-
- Smith M. Patent protection for pharmaceutical products (BP354e). Ottawa (ON): Library of Parliament/Parliamentary Research Branch; 1993. Available: http://publications.gc.ca/Collection-R/LoPBdP/BP/bp354-e.htm (accessed 2012 July 17).
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources